<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html xmlns:o="urn:schemas-microsoft-com:office:office" __expr-val-dir="ltr" dir="ltr"><head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
<meta name="GENERATOR" content="Microsoft SharePoint"/><meta name="progid" content="SharePoint.WebPartPage.Document"/><meta http-equiv="Expires" content="0"/><title>
	Proposed Revision | APA DSM-5
</title><link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/HtmlEditorCustomStyles.css"/>
<link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/HtmlEditorTableFormats.css"/>
<link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/core.css"/>
<link rel="stylesheet" type="text/css" href="../../Style Library/DSM_Css/DSM.css"/>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/init.js"></script>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/core.js" defer></script>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/non_ie.js"></script>
<link type="text/xml" rel="alternate" href="http://www.dsm5.org/proposedrevision/_vti_bin/spsdisco.aspx"/>
	<style type="text/css">
		#DSM_MainContent {
			background-color: transparent;
			padding: 0px;
		}			
	</style>
<!--[if gte mso 9]><xml>
<o:CustomDocumentProperties>
<o:PublishingContactPicture msdt:dt="string" dt="string">, </o:PublishingContactPicture></o:CustomDocumentProperties></xml><![endif]-->
<script type="text/javascript" src="../../_layouts/Emagination.jQuery/jquery-1.3.2.min.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery/jquery.easing.1.3.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery.SPServices/jquery.SPServices-0.5.7.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery.SPServices/jquery.SPServices-0.5.7.min.js"></script><script language="javascript" src="../../Style Library/DSM_js/RevisionTabs.js" type="text/javascript"></script><script language="javascript" src="../../Style Library/DSM_js/search.js" type="text/javascript"></script></head><body style="background:url(../../Style%20Library/DSM_Images/background.gif) repeat-x;margin:0px;" scroll="yes" onload="javascript:if (typeof(_spBodyOnLoadWrapper) != 'undefined') _spBodyOnLoadWrapper();"><form name="aspnetForm" method="post" action="../../ProposedRevision/Pages/proposedrevision_rid_412.html" id="aspnetForm">
<input type="hidden" name="MSO_PageHashCode" id="MSO_PageHashCode" value="5295-48993826"/>
<input type="hidden" name="__SPSCEditMenu" id="__SPSCEditMenu" value="true"/>
<input type="hidden" name="MSOWebPartPage_PostbackSource" id="MSOWebPartPage_PostbackSource" value=""/>
<input type="hidden" name="MSOTlPn_SelectedWpId" id="MSOTlPn_SelectedWpId" value=""/>
<input type="hidden" name="MSOTlPn_View" id="MSOTlPn_View" value="0"/>
<input type="hidden" name="MSOTlPn_ShowSettings" id="MSOTlPn_ShowSettings" value="False"/>
<input type="hidden" name="MSOGallery_SelectedLibrary" id="MSOGallery_SelectedLibrary" value=""/>
<input type="hidden" name="MSOGallery_FilterString" id="MSOGallery_FilterString" value=""/>
<input type="hidden" name="MSOTlPn_Button" id="MSOTlPn_Button" value="none"/>
<input type="hidden" name="__REQUESTDIGEST" id="__REQUESTDIGEST" value="0x0C080C627D95F1BED695B2A36BF43C10494A81BC02AA357D078A1E6AA83A0702E418472BCDC3220541B47FCFD5935C980007C53A1EA4F644F18FDB4CF3D541C1,20 Oct 2012 11:51:04 -0000"/>
<input type="hidden" name="MSOAuthoringConsole_FormContext" id="MSOAuthoringConsole_FormContext" value=""/>
<input type="hidden" name="MSOAC_EditDuringWorkflow" id="MSOAC_EditDuringWorkflow" value=""/>
<input type="hidden" name="MSOSPWebPartManager_DisplayModeName" id="MSOSPWebPartManager_DisplayModeName" value="Browse"/>
<input type="hidden" name="MSOWebPartPage_Shared" id="MSOWebPartPage_Shared" value=""/>
<input type="hidden" name="MSOLayout_LayoutChanges" id="MSOLayout_LayoutChanges" value=""/>
<input type="hidden" name="MSOLayout_InDesignMode" id="MSOLayout_InDesignMode" value=""/>
<input type="hidden" name="MSOSPWebPartManager_OldDisplayModeName" id="MSOSPWebPartManager_OldDisplayModeName" value="Browse"/>
<input type="hidden" name="MSOSPWebPartManager_StartWebPartEditingName" id="MSOSPWebPartManager_StartWebPartEditingName" value="false"/>
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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"/>
<script> var MSOWebPartPageFormName = 'aspnetForm';</script>
<script type="text/javascript">
//<![CDATA[
                function DoCallBack(filterText)
                {
                    WebForm_DoCallback('ctl00$m$g_df258af6_3061_4b80_a680_48204ee9cef4',filterText,UpdateFilterCallback,0,CallBackError,true);
                }
                function CallBackError(result, clientsideString)
                {                
                }
var globalArg_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71;
var globalContext_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71;
function ExpGroupCallServerg_3cf5e074_39b0_425f_92e8_f3c760a6ce71(arg, context)
{
    globalArg_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71 = "GroupString=" + arg + "&ConnectionFilterString=";
    globalContext_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71 = context;
    setTimeout("WebForm_DoCallback('ctl00$m$g_3cf5e074_39b0_425f_92e8_f3c760a6ce71',globalArg_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71,ExpGroupReceiveData,globalContext_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71,ExpGroupOnError,true)", 0);
}
function ExpGroupOnError(message, context) {
alert('An error has occurred with the data fetch.  Please refresh the page and retry.');
}
if (typeof(_spBodyOnLoadFunctionNames) != "undefined") {
if (_spBodyOnLoadFunctionNames != null) {
_spBodyOnLoadFunctionNames.push("ExpGroupOnPageLoad");
}
}//]]>
</script>
<script src="../../WebResource.axd_d_T_sWwmChWv5_0o-vuzl71g2_t_633965588901821931.js" type="text/javascript"></script>
<!-- begin MAIN LAYOUT -->
		<div id="DSM_MainContainer">
			<div id="DSM_Header">	
	<!---- begin ACCESSIBILITY FEATURE ---->
					<div id="TurnOnAccessibility" style="display:none">
			   		<a href="#" class="ms-skip" onclick="SetIsAccessibilityFeatureEnabled(true);UpdateAccessibilityUI();return false;">
					Turn on more accessible mode</a></div>
					<a href="javascript:;" onclick="javascript:this.href='#mainContent';" class="ms-skip" accesskey="J">
					Skip to main content</a>
			  		<div id="TurnOffAccessibility" style="display:none">
					<a href="#" class="ms-acclink" onclick="SetIsAccessibilityFeatureEnabled(false);UpdateAccessibilityUI();return false;">
					Turn off more accessible mode</a></div>
	<!---- end ACCESSIBILITY FEATURE ---->
	<!-- begin UPPER BAR for SITE ACTIONS and EDITING ELEMENTS -->
	<div id="SP_adminBar">
		<tr><td colspan="4" id="mpdmconsole" class="ms-consolemptablerow">
<!-- Console -->
<span id="ctl00_SPNavigation_ctl01_publishingContext1"></span>
<!-- Console -->
</td></tr>
	</div>
<!-- end UPPER BAR for SITE ACTIONS and EDITING ELEMENTS -->
				<h1><a href="/">American Psychiatric Association DSM-5 Development</a></h1>	
				<div id="DSM_UtilityLinks"><a href="http://www.psychiatry.org/">www.psychiatry.org</a></div>
				<!--<div id="DSM_UtilityLinks3"><a href="/pages/registration.aspx">Volunteer for Field Trials</a></div>-->
				<div id="DSM_UtilityLinks2"><a href="../../Pages/TermsandConditionsofUse.html">Terms and Conditions of Use</a></div>
				<div id="DSM_SearchForm">
					<table>
						<tr>
							<td><input type="text" id="searchTerm" onkeydown="searchSubmitEnter()"/></td>
							<td><img src="../../Style Library/DSM_Images/search.gif" alt="Search" id="searchBtn" onclick="searchSubmitClick()"/></td>
						</tr>
					</table>					
				</div>			
			</div>	
			<div id="DSM_TopNavBar">
<!---- begin TOP NAVIGATION ---->		
			<table id="zz1_TopNavigationMenu" class="ms-topNavContainer" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td onmouseover="Menu_HoverRoot(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun0"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
			<tr>
				<td><a class="DSM_staticNavItem" href="/" accesskey="1">Home</a></td>
			</tr>
		</table></td><td width="0"></td><td><table border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="About DSM-5" id="zz1_TopNavigationMenun1"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../about/Pages/Default.html">About DSM-5</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Meet Us" id="zz1_TopNavigationMenun2"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../MeetUs/Pages/Default.html">Meet Us</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Research Background" id="zz1_TopNavigationMenun3"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../Research/Pages/Default.html">Research Background</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="General Resources" id="zz1_TopNavigationMenun4"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../ProgressReports/Pages/Default.html">General Resources</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="DSM-5 Proposed Revisions" id="zz1_TopNavigationMenun5"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../proposedrevision/Pages/Default.html">Proposed Revisions</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Newsroom" id="zz1_TopNavigationMenun6"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../Newsroom/Pages/Default.html">Newsroom</a></td>
					</tr>
				</table></td><td width="0"></td>
			</tr>
		</table><div id="zz1_TopNavigationMenun1Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="DSM-V Overview" id="zz1_TopNavigationMenun7">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/DSMVOverview.html">DSM-5 Overview: The Future Manual</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Timeline" id="zz1_TopNavigationMenun8">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/Timeline.html">Timeline</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Board of Trustee Principles" id="zz1_TopNavigationMenun9">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/BoardofTrusteePrinciples.html">Board of Trustee Principles</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Frequently Asked Questions" id="zz1_TopNavigationMenun10">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/faq.html">Frequently Asked Questions</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun1ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun1ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun2Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Task Force Members" id="zz1_TopNavigationMenun11">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../MeetUs/Pages/TaskForceMembers.html">Task Force Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Study Group Members" id="zz1_TopNavigationMenun12">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../MeetUs/Pages/StudyGroupMembers.html">Study Group Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Work Group Members" id="zz1_TopNavigationMenun13">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../MeetUs/Pages/WorkGroupMembers.html">Work Group Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun14">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/BoardofTrusteePrinciples.html">Board of Trustee Principles</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun2ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun2ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun3Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun15">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Research/Pages/ConferenceSummariesandMonographs.html">DSM-5 Research Planning Conference Summaries and Monographs</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun16">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Research/Pages/Presentations.html">Presentations on DSM-5 and Related Topics</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun17">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Research/Pages/Publications.html">Publications from DSM-5 Development</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun18">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Research/Pages/DSM-5FieldTrials.html">DSM-5 Field Trials</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun3ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun3ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun5Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Neurodevelopmental Disorders" id="zz1_TopNavigationMenun19">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/NeurodevelopmentalDisorders.html">Neurodevelopmental Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Schizophrenia Spectrum and Other Psychotic Disorders" id="zz1_TopNavigationMenun20">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/SchizophreniaSpectrumandOtherPsychoticDisorders.html">Schizophrenia Spectrum and Other Psychotic Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Bipolar and Related Disorders" id="zz1_TopNavigationMenun21">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/BipolarandRelatedDisorders.html">Bipolar and Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Depressive Disorders" id="zz1_TopNavigationMenun22">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/DepressiveDisorders.html">Depressive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Anxiety Disorders" id="zz1_TopNavigationMenun23">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/AnxietyDisorders.html">Anxiety Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Obsessive-Compulsive and Related Disorders" id="zz1_TopNavigationMenun24">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/Obsessive-CompulsiveandRelatedDisorders.html">Obsessive-Compulsive and Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Trauma and Stressor Related Disorders" id="zz1_TopNavigationMenun25">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/TraumaandStressorRelatedDisorders.html">Trauma- and Stressor-Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Dissociative Disorders" id="zz1_TopNavigationMenun26">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/DissociativeDisorders.html">Dissociative Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Somatic Symptom Disorders" id="zz1_TopNavigationMenun27">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/SomaticSymptomDisorders.html">Somatic Symptom Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Feeding and Eating Disorders" id="zz1_TopNavigationMenun28">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/FeedingandEatingDisorders.html">Feeding and Eating Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Elimination Disorders" id="zz1_TopNavigationMenun29">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/EliminationDisorders.html">Elimination Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Sleep-Wake Disorders" id="zz1_TopNavigationMenun30">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/Sleep-WakeDisorders.html">Sleep-Wake Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Sexual Dysfunctions" id="zz1_TopNavigationMenun31">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/SexualDysfunctions.html">Sexual Dysfunctions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Gender Dysphoria" id="zz1_TopNavigationMenun32">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/GenderDysphoria.html">Gender Dysphoria</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Disruptive, Impulse Control, and Conduct Disorders" id="zz1_TopNavigationMenun33">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/Disruptive_ImpulseControl_andConductDisorders.html">Disruptive, Impulse Control, and Conduct Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Substance Use and Addictive Disorders" id="zz1_TopNavigationMenun34">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/SubstanceUseandAddictiveDisorders.html">Substance Use and Addictive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Neurocognitive Disorders" id="zz1_TopNavigationMenun35">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/NeurocognitiveDisorders.html">Neurocognitive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Personality Disorders" id="zz1_TopNavigationMenun36">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/PersonalityDisorders.html">Personality Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Paraphilic Disorders" id="zz1_TopNavigationMenun37">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/ParaphilicDisorders.html">Paraphilic Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Other Disorders" id="zz1_TopNavigationMenun38">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/OtherDisorders.html">Other Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Proposed DSM-5 Organizational Structure and Disorder Names" id="zz1_TopNavigationMenun39">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/proposed-dsm5-organizational-structure-and-disorder-names.html">Proposed DSM-5 Organizational Structure and Disorder Names</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Proposed Mental Disorder Definitions" id="zz1_TopNavigationMenun40">
					<td><table class="DSM_dynamicNavSelected DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavSelected DSM_dynamicNavItem" href="../../proposedrevision/Pages/proposedrevision_rid_465.html">Proposed Mental Disorder Definitions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun41">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/Cult.html">DSM-5 Cultural Formulation Interview</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun5ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun5ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun6Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun42">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Newsroom/Pages/PressReleases.html">Press Releases</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun43">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Newsroom/Pages/MediaContact.html">Media Contact</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="FAQ" id="zz1_TopNavigationMenun44">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/faq.html">Frequently Asked Questions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun45">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Newsroom/Pages/Commentaries.html">Commentaries, Responses, and Other DSM-5 News </a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun6ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun6ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div></td>
	</tr>
</table>
<!---- end TOP NAVIGATION ---->
		</div>
			<div id="DSM_MainContent">
<!---- begin MAIN CONTENT AREA ---->
		<a name="mainContent"></a>
	<div id="DSM_LeftCol">												
		<table width="100%" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td id="MSOZoneCell_WebPartWPQ1" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="df258af6-3061-4b80-a680-48204ee9cef4" haspers="false" id="WebPartWPQ1" width="100%" allowdelete="false" style=""><div id="DSM_Breadcrumbs" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><script>top.document.title ="APA DSM-5 |  Attenuated Psychosis Syndrome (Proposed for Section III of the DSM-5) "</script><span><a class="DSM_bcNode" href="/">Home</a></span><span class="DSM_bcSeparator"> / </span><span><a class="DSM_bcNode" title="Proposed Revisions" href="../../proposedrevision/Pages/Default.html">
				Proposed Revisions
			</a></span><span class="DSM_bcSeparator"> / </span><span class="DSM_bcNode"><a target="_self" href="../../ProposedRevision/Pages/.html"></a></span><span class="DSM_bcSeparator"> / </span><span class="DSM_bcNode"></span><span class="DSM_bcSeparator"> / </span><span class="DSM_bcCurrent"> Attenuated Psychosis Syndrome (Proposed for Section III of the DSM-5) </span></div><table cellspacing="0" cellpadding="4" border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr></tr></table></div></td>
			</tr>
		</table><div class="ms-PartSpacingVertical"></div></td>
	</tr><tr>
		<td id="MSOZoneCell_WebPartWPQ2" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="c31544f0-05e5-4027-985a-b5882502a9eb" haspers="false" id="WebPartWPQ2" width="100%" allowdelete="false" style=""><table border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr><td><table border="0" cellspacing="0" width="100%"><tr><td><h1><span><br>Attenuated Psychosis Syndrome (Proposed for Section III of the DSM-5) </span></h1><div class="DSM_TabBar"><ul><li><a href="#" id="DSM_Tab_Proposed" class="DSM_TabOn" onclick="TabClick('Proposed','Rationale','Severity','DSM-IV')">Proposed   
								&nbsp;Revision</a></li><li><a href="#" id="DSM_Tab_Rationale" class="DSM_TabOff" onclick="TabClick('Rationale','Proposed','Severity','DSM-IV')">Rationale</a></li><li><a href="#" id="DSM_Tab_Severity" class="DSM_TabOff" onclick="TabClick('Severity','Proposed','Rationale','DSM-IV')">Severity</a></li><li><a href="#" id="DSM_Tab_DSM-IV" class="DSM_TabOff" onclick="TabClick('DSM-IV','Proposed','Rationale','Severity')">DSM-IV</a></li></ul><div class="DSM_clear"><img src="../../Style Library/DSM_Images/clear.gif" width="0" height="0" alt=""></div></div><div id="DSM_TabContent_Proposed"><font size="2" face="Arial"><span style="font-family:'arial', 'sans-serif';font-size:10pt">
<p><font size="2" face="Arial"><strong><font color="#000080">Attenuated Psychosis Syndrome</font> </strong></font></p></span></font>
<p align="right"><font size="2" face="Arial"><em><span style="font-family:'arial', 'sans-serif';font-size:10pt">Updated April-27-2012</span></em></font><font size="2" face="Arial"></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">This condition is being recommended for further study in Section III, which is the section of the DSM-5 text in which conditions that require further research will be included.</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"></span></font><font size="2" face="Arial"> </p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span style="font-family:'arial','sans-serif';font-size:10pt"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>A.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">At least one of the following symptoms are present in attenuated form with relatively intact reality testing, but of sufficient severity and/or frequency to warrant clinical attention:</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><span style="font:7pt 'times new roman'">           </span>1.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">delusions/delusional ideas</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><span style="font:7pt 'times new roman'">           </span>2.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">hallucinations/perceptional abnormalities</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><span style="font:7pt 'times new roman'">           </span>3.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">disorganized speech/communication</span></p>
<p style="line-height:normal;margin:0in 0in 6pt 0.5in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>B.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Symptoms in Criterion A must be present at least once per week for the past month.</span></p>
<p style="line-height:normal;margin:0in 0in 6pt 0.25in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>C.<span style="font:7pt 'times new roman'">    </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Symptoms in Criterion A must have begun or worsened in the past year.</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>D.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Symptoms in Criterion A are sufficiently distressing and disabling to the individual and/or legal guardian to lead them to seek help.</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>E.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Symptoms in Criterion A are not better explained by any other DSM-5 diagnosis, including Substance-Related Disorders.</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>F.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Clinical criteria for a Psychotic Disorder have never been met.</span></p></span>
<p style="line-height:normal;text-indent:-9pt;margin:0in 0in 6pt 9pt" class="MsoNormal"></span>
<p style="text-justify:inter-ideograph;text-align:justify" class="MsoNormal"></font><font size="2"><font face="Arial"></p><span style="font-family:'arial','sans-serif';font-size:10pt"></span>
<p></p></font></font></div><div id="DSM_TabContent_Rationale"><p style="margin:0in 0in 0pt" class="MsoNormal" align="center"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Rationale for Including Attenuated Psychosis Syndrome (APS) in Section 3 (Appendix) of DSM-5 </span></b></p>
<p style="margin:0in 0in 0pt" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt"></span></b> </p>
<p style="margin:0in 0in 0pt" class="MsoNormal" align="right"><span style="font-family:'arial','sans-serif';font-size:10pt"><em>Updated May 16, 2012</em></span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal" align="left"><b><u><span style="font-family:'arial','sans-serif';font-size:10pt"></span></u></b> </p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal" align="left"><b><u><span style="font-family:'arial','sans-serif';font-size:10pt">Introduction</span></u></b></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">Despite therapeutic advances over the past half-century, schizophrenia continues to be a debilitating disorder with profound lifelong impairments in social and vocational functioning for most of those with the condition. Much of the decline occurs early in the course of the illness and overall outcome is directly correlated with functional ability prior to onset of psychosis and inversely correlated with duration of untreated psychosis. These facts have provided the impetus to early intervention efforts for those with schizophrenia. Reducing treatment delay from the onset of the initial psychotic episode by early diagnosis and effective treatment has yielded only modest improvements in outcome for individuals with schizophrenia, however, leading to interest in possibilities for intervention even earlier in the course of the illness (i.e., before onset of psychosis). Over the past two decades, several centers around the world have developed early psychosis detection and treatment programs to investigate their utility.<span>  </span><span> </span></span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">To address this need and based on the experience of the various early psychosis programs, the Psychotic Disorders workgroup has carefully considered the addition in DSM-5 of a new category of “Psychosis Risk Syndrome” or<span>  </span>“Attenuated Psychosis Syndrome” to describe a condition with recent onset of modest, psychotic-like symptoms and clinically relevant distress and disability.<span>  </span>These patients also are at significantly increased risk of conversion to a full-blown psychotic disorder. Based on a review of the data relatively early in the process, it was realized that it may be premature to recommend a new category primarily based on future risk (i.e., “Psychosis Risk Syndrome”) and not on current clinical need. We recognized that a majority of individuals with this condition did <u>not</u> go on to develop a psychotic disorder and that most individuals with this condition had additional relevant clinical needs other than risk of conversion to psychosis. Consequently, a condition that described current clinical need (“Attenuated Psychosis Syndrome”) was considered instead. In contrast to “Psychosis Risk Syndrome”, APS describes a currently relevant clinical condition leading to help-seeking and has many more clinical outcomes other than conversion to psychosis. </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">Over the past few years, the Psychotic Disorders workgroup has extensively reviewed all available data, consulted a range of experts, and carefully considered the variety of public and expert comments on the topic. Based on this review, the Workgroup has decided to recommend the inclusion of Attenuated Psychosis Syndrome as a category in the appendix (Section 3) of DSM-5 as a condition for further study. </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><b><u><span style="font-family:'arial','sans-serif';font-size:10pt">Rationale</span></u></b></p>
<p style="line-height:normal;text-indent:-0.25in;margin:0in 0in 6pt 40.5pt" class="MsoListParagraph"><b><span style="font-family:'arial','sans-serif';font-size:10pt"><span>A.<span style="font:7pt 'times new roman'">     </span></span></span></b><b><u><span style="font-family:'arial','sans-serif';font-size:10pt">Why Include it?</span></u></b></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">The condition can be diagnosed with high reliability. <span>Several reliable and validated instruments exist to assess the presence or absence of APS and these were utilized in the construction of specific APS criteria for field-testing.</span> Individuals who meet these criteria for APS have a 500-1000 fold greater risk of developing schizophrenia or other psychotic disorder over the next year than the general population. A range of interventions, including close follow-up and careful monitoring, has been found to result in a reduction in the rates of conversion to psychosis. The fairly extensive validity data are summarized below: <span> </span></span></p>
<p style="text-align:center;line-height:normal;margin-bottom:6pt" class="MsoNormal" align="center"><u><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">SUMMARY OF APS VALIDITY DATA</span></u></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">Criteria employed to select studies</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">: Highest Impact Factor journals and most recent papers. </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">Authoritative/comprehensive reviews</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">: AGP conceptual review by 23 leading experts from different centers</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>1</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">. </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">Outcomes</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">: </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">-<i>Transition risks</i>: meta analysis in 27 HR (At Risk Mental States [ARMS], APS) studies, relating to 2502 HR [High Risk] subjects: 18% (95%CI 12.3%-24.9%) after six months of follow-up, 22% (95%CI 16.6%-27.8%) after one year, 29% (95%CI 23.3%-35.7%) after two years and 36% (29.6%-42.5%) after three years. <span> </span>These data come from clinically treated cohorts. </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">Moderators: <span>modest but significant increase of transition risk with increasing age of HR subjects, greater risk under BS (Basic Symptoms) criteria and similar risk between SIPS [Structured Interview for Prodromal Syndromes] and ARMS, modest but significant effect towards declining transition risks in the most recent published papers</span></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>2</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">, modulating effect of psychotic threshold used</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>3</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">. </span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"></span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">-<i>Diagnostic outcomes</i> (n=560 high risk patients with transition to psychosis): 73% schizophrenic (schizophrenia, schizophreniform, schizoaffective) and 11% affective (psychotic depression, bipolar psychosis) psychoses (Relative Risk = 5.4)</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>4</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">.</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">-<i>Remission</i>: Systematic review </span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>5</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> uncovering s</span><span style="font-family:'arial','sans-serif';font-size:10pt">ix studies that reported remission rates from initial HR status (proportion of remissions ranged from 15.4% to 54.3%). </span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"></span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">Interventions</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">: Three meta-analyses addressing RCTs. Preti et al</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>6</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> showed that “receiving any of the focused treatment was associated with a lower risk of developing psychosis if compared with no treatment or treatment as usual” (Relative Risk=0.36; 95%CI: 0.22–0.59). A third updated meta-analysis is presented in Table III of </span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>1</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">: “a significant effect of active treatments, with a risk ratio of 0.34 (from 23% to 7%, p&lt;0.001) and a <u>NTT [Numbers Needed to Treat] of 6</u> in the focused treatments versus the contrast group at one year”. </span></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> </span></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">Cognition:</span></b></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">Two meta-analyses by Giuliano/Seidman </span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>7</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> and Fusar-Poli et al.</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>8</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">. The latter (19 studies, 1188 HR, 1029 C) showed </span><span style="font-family:'arial','sans-serif';font-size:10pt">HR subjects were impaired on tests of general intelligence, executive functions, verbal/visual memory, verbal fluency, attention and working memory and social cognition</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>8</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt">. Transition to psychosis was associated with deficits in the verbal fluency and memory domains</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>8</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt">.</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"></span></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> </span></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">Imaging:</span></b></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">-Neuroanatomy: recent meta-analysis of voxel-based morphometry [VBM] studies</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>9</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">. Best paper (for Iimpact factor: Pantelis et al</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>10</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">. Largest multicenter VBM structural study by Mechelli et al</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>11</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> in 182 HR and 167 controls showing that the HR </span><span style="font-family:'arial','sans-serif';font-size:10pt">group as a whole had less gray matter volume than did controls in the frontal regions. The HR who later developed psychosis had less gray matter volume in the parahippocampal cortex than the HR subgroup who did not. </span></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">-Neurochemistry: Howes et al. showed elevation of pre-synaptic dopamine synthesis capacity is associated with both risk</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>13</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> and transition</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>14</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> to psychosis (meta-analytical evidence for a 14% increase of pre-synaptic dopamine synthesis capacity in established schizophrenia vs controls</span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><sup><span>15</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">). </span><span style="font-family:'arial','sans-serif';font-size:10pt">Multimodal fMRI-PET and MRS-fMRI studies in the HR available</span><span style="font-family:'arial','sans-serif';font-size:10pt"><sup><span>16, 17</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt">. </span></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></b></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Neurophysiology/Genetic:</span></b></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">Systematic review by Crossley/Bramon</span><span style="font-family:'arial','sans-serif';font-size:10pt"><sup><span>18</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt"> (P300 mainly). Neuregulin implicated in clinical high risk subjects</span><span style="font-family:'arial','sans-serif';font-size:10pt"><sup><span>19</span></sup></span><span style="font-family:'arial','sans-serif';font-size:10pt">.</span></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> </span></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><u><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">References</span></u></p>
<p style="line-height:normal;margin-bottom:6pt;text-autospace:" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"> </span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><b><span>1.</span></b><span><span>         </span>Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman L, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkötter J, McGuire P, Yung A. The psychosis high risk state: a comprehensive state of the art review <i>Arch Gen Psychiatry. </i>2012:in press.</span></span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">2.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>         </span>Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, Phillips L, McGorry P. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? <i>Schizophr Bull. </i>May 2007;33(3):673-681.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">3.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>         </span>Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton M, Barale F, Caverzasi E, McGuire P. Predicting psychosis: a meta-analysis of transition outcomes in individuals at high clinical risk. <i>Arch Gen Psychiatry. </i>2012;69(3):1-10.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">4.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>         </span>Fusar-Poli P, Bechdolf A, Taylor M, Bonoldi I, Carpenter W, Yung A, McGuire P. At risk for schizophrenic or affective psychosis? A meta-analysis of ICD/DSM diagnostic outcomes in individuals at high clinical risk <i>Schizophr Bull. </i>2012:in press.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">5.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>         </span>Simon AE, Velthorst E, Nieman DH, Linszen D, Umbricht D, de Haan L. Ultra high-risk state for psychosis and non-transition: A systematic review. <i>Schizophr Res. </i>Jul 22 2011.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">6.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>         </span>Preti A, Cella M. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. <i>Schizophr Res. </i>Oct 2010;123(1):30-36.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">7.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>         </span>Giuliano AJ, Li H, Mesholam-Gately RI, Sorenson SM, Woodberry KA, Seidman LJ. Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. <i>Curr Pharm Des. </i>2012;18(4):399-415.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">8.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>         </span>Fusar-Poli P, Deste G, Smieskova R, Barlati G, Yung AR, Howes O, Stieglitz R, McGuire P, Borgwardt S. Cognitive functioning in prodromal psychosis: a meta-analysis. <i>Arch Gen Psychiatry. </i>2012:in press.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">9.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>         </span>Fusar-Poli P, Radua J, McGuire P, Borgwardt S. Neuroanatomical Maps of Psychosis Onset: Voxel-wise Meta-Analysis of Antipsychotic-Naive VBM Studies. <i>Schizophr Bull. </i>2011:Epub.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">10.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>       </span>Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, Yung AR, Bullmore ET, Brewer W, Soulsby B, Desmond P, McGuire PK. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. <i>Lancet. </i>Jan 25 2003;361(9354):281-288.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">11.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>       </span>Mechelli A, Riecher-Rossler A, Meisenzahl EM, Tognin S, Wood SJ, Borgwardt SJ, Koutsouleris N, Yung AR, Stone JM, Phillips LJ, McGorry PD, Valli I, Velakoulis D, Woolley J, Pantelis C, McGuire P. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. <i>Arch Gen Psychiatry. </i>May 2011;68(5):489-495.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">12.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>       </span>Koutsouleris N, Meisenzahl EM, Davatzikos C, Bottlender R, Frodl T, Scheuerecker J, Schmitt G, Zetzsche T, Decker P, Reiser M, Moller HJ, Gaser C. Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. <i>Arch Gen Psychiatry. </i>Jul 2009;66(7):700-712.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">13.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>       </span>Howes O, Montgomery A, Asselin M, Valli I, Tabraham P, Johns L, Valmaggia L, Broome M, Bramon-Bosch E, Murray R, McGuire P, Grasby P. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. <i>Archives of General Psychiatry. </i>2009;66(1):13-20.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">14.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>       </span>Howes OD, Bose SK, Turkheimer F, Valli I, Egerton A, Valmaggia LR, Murray RM, McGuire P. Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study. <i>Am J Psychiatry. </i>Jul 18 2011.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">15.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>       </span>Fusar-Poli P, Meyer-Lindenberg A. Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [18F]/[11C] DOPA PET studies. <i>Schizophr Bull. </i>2012:Jan 26 Epub.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">16.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>       </span>Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, Grasby PM, McGuire PK. Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. <i>Arch Gen Psychiatry. </i>Jul 2010;67(7):683-691.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">17.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>       </span>Fusar-Poli P, Stone J, Broome M, Valli I, Mechelli A, McLean M, Lythgoe D, O'Gorman R, Barker G, McGuire P. Thalamic glutamate levels predicts cortical response during executive functioning in subjects at high risk for psychosis. <i>Arch Gen Psychiatry. </i>2011:May 2, Epub.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">18.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>       </span>Crossley NA, Constante M, Fusar-Poli P, Bramon E. Neurophysiological alterations in the prepsychotic phases. <i>Curr Pharm Des. </i>2012;18(4):479-485.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">19.</span></b><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"><span>       </span>Keri S, Kiss I, Kelemen O. Effects of a neuregulin 1 variant on conversion to schizophrenia and schizophreniform disorder in people at high risk for psychosis. <i>Molecular Psychiatry. </i>Feb 2009;14(2):118-119.</span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB"></span> </p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt"><span>B.<span style="font:7pt 'times new roman'">     </span></span></span></b><b><u><span style="font-family:'arial','sans-serif';font-size:10pt" lang="EN-GB">Why Not Include it in the Main Text?</span></u></b><b><u><span style="font-family:'arial','sans-serif';font-size:10pt"></span></u></b></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">A majority of help-seeking persons with APS have significant other psychiatric comorbidities warranting current clinical attention and a significant proportion either shows a relative resilience to psychiatric disorder or progress to adverse psychiatric outcomes other than development of schizophrenia or other psychotic disorder. A majority of individuals with current APS have some other <u>current</u> psychiatric comorbidity (frequently depressive, anxiety, or substance use disorder) which warrants appropriate treatment. A substantial proportion of individuals with APS do not go on to develop major psychopathology. Whereas conversion to schizophrenia or other full-blown psychosis is one possible outcome of APS, this occurs in a minority of persons. Although a range of interventions (including careful observation and monitoring) appear to be effective in reducing rates of conversion to psychosis, they are inadequately differentiated at present and require additional study. Close follow-up is important and should include assessment for conversion to psychosis as also </span><span style="font-family:'arial','sans-serif';font-size:10pt">a<span>ssessment for development or persistence of other psychiatric conditions and provision of appropriate treatment.</span></span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">APS is therefore most often seen as a “comorbidity” that occurs in the context of some other mental disorder (generally, depressive and anxiety disorders) and it is unclear whether it represents a special type of that condition (to be designated as a subtype or with a specifier) or if it represents a distinct condition. Furthermore, it is unclear if APS represents a trait or state vulnerability (for increased risk of development of a psychotic disorder) and its relationship to schizotypal personality disorder is not clear. Additionally, it is unclear if the distress and/or disability resulting in help-seeking behavior by this group of individuals is related to APS or the “comorbid” mental disorder; help-seeking is part of its definition in DSM-5. Finally, current data are inadequate to have confidence in the likelihood of reliable implementation of APS criteria in routine clinical settings. In view of the preliminary nature of various validators and its uncertain nosologic status, more work is necessary before APS can be considered for inclusion in the main body of DSM. </span></p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"> </p>
<p style="line-height:normal;text-indent:-0.5in;margin:0in 0in 6pt 0.5in" class="MsoNormal"><b><u><span style="font-family:'arial','sans-serif';font-size:10pt">Summary.<span>  </span></span></u></b><span style="font-family:'arial','sans-serif';font-size:10pt">The workgroup concluded that there were strong reasons to continue to evaluate this clinical entity and provision of specific criteria and description (text to accompany its inclusion in the appendix) would help in this effort. Data were found not to be sufficient to recommend its inclusion in the main body of the text. </span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></b></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><b><u><span style="font-family:'arial','sans-serif';font-size:10pt">Proposed Clinical Criteria for APS in DSM-5<span></span></span></u></b></p>
<p style="line-height:normal;text-indent:-1in;margin:0in 0in 6pt 1in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><span style="font:7pt 'times new roman'">                         </span>A.<span style="font:7pt 'times new roman'">          </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">At least one of the following symptoms are present in attenuated form with relatively intact reality testing, but of sufficient severity and/or frequency to warrant clinical attention:</span></p>
<p style="line-height:normal;text-indent:-1.5in;margin:0in 0in 6pt 1.5in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><span style="font:7pt 'times new roman'">                                                   </span>1.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">delusions/delusional ideas</span></p>
<p style="line-height:normal;text-indent:-1.5in;margin:0in 0in 6pt 1.5in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><span style="font:7pt 'times new roman'">                                                   </span>2.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">hallucinations/perceptional abnormalities</span></p>
<p style="line-height:normal;text-indent:-1.5in;margin:0in 0in 6pt 1.5in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><span style="font:7pt 'times new roman'">                                                   </span>3.<span style="font:7pt 'times new roman'">     </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">disorganized speech/communication</span></p>
<p style="line-height:normal;text-indent:-1in;margin:0in 0in 6pt 1in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><span style="font:7pt 'times new roman'">                         </span>B.<span style="font:7pt 'times new roman'">          </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Symptoms in Criterion A must be present at least once per week for the past month.</span></p>
<p style="line-height:normal;text-indent:-1in;margin:0in 0in 6pt 1in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><span style="font:7pt 'times new roman'">                         </span>C.<span style="font:7pt 'times new roman'">          </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Symptoms in Criterion A must have begun or worsened in the past year.</span></p>
<p style="line-height:normal;text-indent:-1in;margin:0in 0in 6pt 1in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><span style="font:7pt 'times new roman'">                         </span>D.<span style="font:7pt 'times new roman'">          </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Symptoms in Criterion A are sufficiently distressing and disabling to the individual and/or legal guardian to lead them to seek help.</span></p>
<p style="line-height:normal;text-indent:-1in;margin:0in 0in 6pt 1in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><span style="font:7pt 'times new roman'">                         </span>E.<span style="font:7pt 'times new roman'">          </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Symptoms in Criterion A are not better explained by any other DSM-5 diagnosis, including Substance-Related Disorders.</span></p>
<p style="line-height:normal;text-indent:-1in;margin:0in 0in 6pt 1in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><span style="font:7pt 'times new roman'">                         </span>F.<span style="font:7pt 'times new roman'">          </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Clinical criteria for a Psychotic Disorder have never been met.</span></p>
<p style="margin:0in 0in 0pt" class="MsoNormal"> </p></div><div id="DSM_TabContent_Severity"><div style="display:inline" id="ctl00_m_g_f7094959_4272_49f5_a3fd_5fec8167517e_ctl00_ctl04_ctl04_ctl00_ctl00_ctl05_ctl00__ControlWrapper_RichHtmlField">
<div style="display:inline" id="ctl00_m_g_f7094959_4272_49f5_a3fd_5fec8167517e_ctl00_ctl04_ctl04_ctl00_ctl00_ctl05_ctl00__ControlWrapper_RichHtmlField">
<p align="left"><span><font size="2" face="Arial">Dimensions will be assessed on a 0-4 scale cross-sectionally, with severity assessment based on past month. <span><font size="2"><font face="Arial">There are distinct psychopathological domains in psychotic illnesses (most clearly noted in schizophrenia) with distinctive patterns of treatment-response, prognostic implications, and course. The relative severity of symptoms across these domains varies across the course of illness and among patients. This is a ma<span>jor change that will potentially be of great clinical value and will also be of additional research utility.</span></font></font></span></font></p>
<p style="text-justify:inter-ideograph;text-align:justify;tab-stops:list .5in" class="MsoNormal" align="left"><font size="2" face="Arial">  </p>
<p style="text-justify:inter-ideograph;text-align:justify;tab-stops:list .5in" class="MsoNormal" align="left">
<table style="border-bottom:medium none;border-left:medium none;border-collapse:collapse;border-top:medium none;border-right:medium none" class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:17.55pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="23">
<p class="MsoNormal"><span style="font-size:10pt"> </span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:77.2pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="103">
<p class="MsoNormal" align="left"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Hallucinations</span></b><b><span style="font-family:'times','serif';font-size:10pt"></span></b></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:64.6pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="86">
<p class="MsoNormal" align="left"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Delusions</span></b><b><span style="font-family:'times','serif';font-size:10pt"></span></b></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:82.65pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="110">
<p class="MsoNormal" align="left"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Disorganization</span></b><b><span style="font-family:'times','serif';font-size:10pt"></span></b></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:74.35pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="99">
<p class="MsoNormal" align="left"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Abnormal Psychomotor Behavior</span></b></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:70.5pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="94">
<p class="MsoNormal" align="left"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Restricted Emotional Expression</span></b><b><span style="font-family:'times','serif';font-size:10pt"></span></b></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:50.55pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="67">
<p class="MsoNormal" align="left"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Avolition</span></b><b><span style="font-family:'times','serif';font-size:10pt"></span></b></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:76.5pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="102">
<p class="MsoNormal" align="left"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Impaired Cognition</span></b><b><span style="font-family:'times','serif';font-size:10pt"></span></b></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:76.5pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="102">
<p class="MsoNormal" align="left"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Depression</span></b><b><span style="font-family:'times','serif';font-size:10pt"></span></b></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:1.1in;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="106">
<p class="MsoNormal" align="left"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Mania</span></b><b><span style="font-family:'times','serif';font-size:10pt"></span></b></p></td></tr>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:17.55pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="23">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">0</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:77.2pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="103">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Not Present</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:64.6pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="86">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Not Present</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:82.65pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="110">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Not Present</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:74.35pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="99">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Not Present</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:70.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="94">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Not Present</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:50.55pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="67">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Not Present</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:76.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="102">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Not Present</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:76.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="102">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Not Present</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:1.1in;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="106">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Not Present</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td></tr>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:17.55pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="23">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">1</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:77.2pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="103">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Equivocal (severity or duration not sufficient to be considered psychosis)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:64.6pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="86">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Equivocal (severity or duration not sufficient to be considered psychosis)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:82.65pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="110">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Equivocal (severity or duration not sufficient to be considered disorganization)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:74.35pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="99">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Equivocal (severity or duration not sufficient to be considered abnormal psychomotor behavior)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:70.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="94">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Equivocal decrease in facial expressivity, prosody, or gestures</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:50.55pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="67">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Equivocal decrease in self-initiated behavior</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:76.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="102">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Equivocal (cognitive function not clearly outside the range expected for age or SES, i.e., within 1 SD of mean)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:76.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="102">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Equivocal (some depressed mood, but insufficient symptoms, duration or severity to meet diagnostic criteria)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:1.1in;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="106">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Equivocal (some inflated or irritable mood, but insufficient symptoms, duration, or severity to meet diagnostic criteria)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td></tr>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:17.55pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="23">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">2</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:77.2pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="103">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present, but mild (little pressure to act upon voices, not very bothered by voices)</span></p>
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt"><span> </span></span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:64.6pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="86">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present, but mild (delusions are not bizarre, or little pressure to act upon delusional beliefs, not very bothered by beliefs)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:82.65pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="110">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present, but mild (some difficulty following speech and/or occasional bizarre behavior)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:74.35pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="99">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present, but mild (occasional abnormal motor behavior)</span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:70.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="94">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present, but mild decrease in facial expressivity, prosody, or gestures</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:50.55pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="67">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present, but mild in self-initiated behavior</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:76.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="102">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present, but mild (some reduction in cognitive function below expected for age and SES, b/w 1 and 2 SD from mean)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:76.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="102">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present, but mild (meets criteria for Major Depression, with minimum number of symptoms, duration, and severity)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:1.1in;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="106">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present, but mild (meets criteria for Mania with minimum number of symptoms, duration, and severity)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td></tr>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:17.55pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="23">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">3</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:77.2pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="103">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and moderate (some pressure to respond to voices, or is somewhat bothered by voices)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:64.6pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="86">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and moderate (some pressure to act upon beliefs, or is somewhat bothered by beliefs)</span></p>
<p class="MsoNormal" align="left"><span style="font-family:'times','serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:82.65pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="110">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and moderate (speech often difficult to follow and/or frequent bizarre behavior)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:74.35pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="99">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and moderate (frequent abnormal motor behavior)</span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:70.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="94">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and moderate decrease in facial expressivity, prosody, or gestures</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:50.55pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="67">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and moderate in self-initiated behavior</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:76.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="102">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and moderate (clear reduction in cognitive function below expected for age and SES, b/w 2 and 3 SD from mean)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:76.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="102">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and moderate (meets criteria for Major Depression with somewhat more than the minimum number of symptoms, duration, and/or severity</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:1.1in;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="106">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and moderate (meets criteria for Mania with somewhat more than the minimum number of symptoms duration, and/or severity)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td></tr>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:17.55pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="23">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">4</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:77.2pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="103">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and severe (severe pressure to respond to voices, or is very bothered by voices)</span></p>
<p class="MsoNormal" align="left"><span style="font-family:'times','serif';font-size:10pt"> </span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:64.6pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="86">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and severe (severe pressure to act upon beliefs, or is very bothered by beliefs)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:82.65pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="110">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and severe (speech almost impossible to follow and/or behavior almost always bizarre)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:74.35pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="99">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and severe (abnormal motor behavior almost constant)</span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:70.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="94">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and severe decrease in facial expressivity, prosody, or gestures</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:50.55pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="67">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and severe in self-initiated behavior</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:76.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="102">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and severe (severe reduction in cognitive function below expected for age and SES, &gt; 3SD from mean)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:76.5pt;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="102">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and severe (meets criteria for Major Depression with many more than the minimum number of symptoms and/or severity)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:medium none;padding-bottom:0in;padding-left:5.4pt;width:1.1in;padding-right:5.4pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="106">
<p class="MsoNormal" align="left"><span style="font-family:'arial','sans-serif';font-size:10pt">Present and severe (meets criteria for Mania with many more than the minimum umber of symptoms and/or severity)</span><span style="font-family:'times','serif';font-size:10pt"></span></p></td></tr></tbody></table></p></font>
<ol style="margin-top:0in" type="1">
<p align="left"><font size="2" face="Arial"> </font></p></ol>
<p align="left"></span><span><span><span><font size="2" face="Arial"><strong>Logic and Justification for Dimensional Assessment of Symptoms and</strong></font></span></p>
<p style="text-align:center;margin-top:6pt" class="MsoNormal" align="left"><span><font size="2" face="Arial"><strong>Related Clinical Phenomena in Psychosis.</strong></font></span></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>Work on the causes and treatment of schizophrenia and other psychotic disorders has long recognized the heterogeneity of the symptoms that can be displayed by individuals with psychosis.<span>  </span>In addition, researchers have increasingly emphasized the ways in which the severity of different symptoms of this illness can vary across individuals, and have provided evidence that the severity of such symptoms can predict other important aspects of the illness, such as the degree of cognitive and/or neurobiological deficits </span><span>(e.g., Barch et al. 2003; Barch et al. 2004; Delawalla et al. 2006; Kerns and Berenbaum 2002; Perlstein et al. 2003; Strauss et al. 1993)</span><span>.<span>  </span>Further, research has increasingly emphasized that the boundaries between nosological entities may not be as categorical as suggested by individuals such as Kraepelin </span><span>(Kraepelin 1971)</span><span>, and putative comorbidity of various disorders may reflect impairments in common dimensions of genetic variation, human behavior and neurobiological function </span><span>(Owen et al. 2007)</span><span>. As such, it is important to explicitly include dimensional assessments of the core symptoms of psychotic disorders to help us identify this important variability.<span>  </span>Thus, we propose to include dimensional assessments of all of the symptoms included as diagnostic indicators in Criterion A of the diagnostic criteria for schizophrenia.<span>  </span>This includes hallucinations, delusions, disorganization, abnormal motor behavior, restricted emotional expression, and avolition.<span>  </span>Each of these symptoms will be rated for their current severity (<u>most severe in the past month)</u> on a five-point scale ranging from 0 (Not Present) to 5 (Present and Severe).<span>  </span>A score of 2 or higher will be considered sufficient severity to fulfill a Criterion A diagnostic Indicator for Schizophrenia.<span>  </span>We believe that including these dimensional assessments will help diagnosticians make reliable decisions about the presence or absence of diagnostic phenomena and that it will help clinicians attend to the clinically meaningful variation in the severity of these symptoms, which will help with treatment planning, prognostic decision making, and research on pathophysiological mechanisms.<span>  </span></span></font></font></p>
<p style="text-align:justify;margin-top:6pt" class="MsoNormal" align="left"><span><font size="2" face="Arial">Hallucinations and Delusions</font></span></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>One might question whether we could collapse some of the symptoms in to a single dimension.<span>  </span>For example, both hallucinations and delusions are considered to be evidence of impaired reality testing, and in theory we could collapse these into a single dimension of reality testing. However, a number of treatment approaches, such as cognitive behavioral therapy, focus on the treatment of hallucinations and delusions in somewhat different ways, and thus we feel it is important for clinicians to have a means by which to separately assess the severity of such symptoms separately and to be able to track change in each domain of symptom individually</span><span>(Addington and Mancuso 2009; Gleeson et al. 2009; Velligan 2009)</span><span>. </span></font></font></p>
<p style="text-align:justify;margin-top:6pt" class="MsoNormal" align="left"><font face="Arial"><span><font size="2">Restricted Emotional Expression and Avolition</font></span><span><font size="2"> </font></span></font></p>
<p style="text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>In addition, we felt it important to distinguish between two different domains of negative symptoms: 1) restricted emotional expression; and 2) avolition. </span><span>Exploratory and confirmatory factor analyses of symptom assessment scales such as the Schedule for the Assessments of Negative Symptoms (SANS) at the item level have overwhelmingly supported separate negative symptom factors for Flat Affect/Diminished Expression and Avolition/Asociality/Anhedonia.<sup>39, 90-97</sup> Factor analytic studies of the SDS have also supported two separate factors of Diminished Emotional Expression and Avolition.<sup>99, 100</sup> Additional support for a two-factor model of negative symptoms comes from replication of the finding across heterogeneous samples. Separate factors for Flat Affect/Diminished Expression and Avolition/Asociality/Anhedonia have been identified in heterogeneous groups of patients with any psychotic disorder<sup>93, 95, 97</sup> as well as schizophrenia spectrum patients<sup>34, 39, 90-92, 94, 96</sup> and deficit syndrome patients.<sup>99, 100</sup> Furthermore, these factors were found in patients on<sup>34, 94, 96, 99</sup> and off medication<sup>39</sup> and in first-episode<sup>92</sup> and chronic<sup>91</sup> patients. Separate factors for affective flattening and avolition appear to hold up cross-culturally. Factor analyses of data collected from patients in the United States,<sup>34, 39, 91, 94, 96, 99</sup> Canada,<sup>92</sup> Spain,<sup>95</sup> South Africa,<sup>90</sup> Australia,<sup>93</sup> and Japan,<sup>100</sup> all supported Flat Affect/Diminished Expression and Avolition/Asociality/Anhedonia as separate factors, providing further evidence for recognizing deficits in affect and volition as two distinct symptom domains in schizophrenia. </span></font></font></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>A primary reason for asking clinicians to rate each of these types of negative symptoms separately is evidence that they may differentially predict factors such as clinical presentation</span><span>(Strauss et al. in submission)</span><span>, functional outcome</span><span>(Strauss et al. in submission; Tattan and Creed 2001)</span><span>, cognitive deficits </span><span>(Gur et al. 2006; Malaspina and Coleman 2003; Suslow et al. 1998)</span><span>, emotional deficits</span><span>(Gur et al. 2006; Henry et al. 2007)</span><span>, and neurobiological impairments</span><span>(Dichter et al. 2009; Dowd and Barch in press; Fahim et al. 2005; Gur et al. 2007; Waltz et al. 2009)</span><span>. </span></font></font></p>
<p style="text-align:justify;margin-top:6pt" class="MsoNormal" align="left"><span><font size="2" face="Arial">Cognitive Function</font></span></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>In addition to including dimensional assessments of the criterial symptoms of psychosis, we feel it is also important to include dimensional assessments of other important clinical phenomena that are relevant to treatment planning and prognosis.<span>  </span>First, we propose to include a dimensional assessment of cognitive impairment.<span>  </span>There is ample evidence that a large percentage of individuals with schizophrenia and other psychotic disorders suffer from impairments in a range of cognitive domains </span><span>(e.g., Reichenberg et al. 2008)</span><span>, and growing evidence that the level of cognitive impairment predicts functional abilities (social, occupational, living status)</span><span> </span><span>(e.g., Cervellione et al. 2007; Green et al. 2004; Heinrichs et al. 2008b; McClure et al. 2007)</span><span>. </span></font></font></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>Despite the importance of cognition to understanding function in schizophrenia and other psychotic disorders, we do not propose to include cognitive deficits as a Criterion A symptom of schizophrenia or any other psychotic disorder.<span>  </span>This is because cognition may not be useful as differential diagnosis tool.<span>  </span>The profile of cognitive impairments in similar across the non-affective and affective psychosis </span><span>(Depp et al. 2007; Hill et al. 2004; Reichenberg et al. 2008; Schretlen et al. 2007; Smith et al. 2009)</span><span>, though the level of impairment may be greater in non-affective psychoses </span><span>(Depp et al. 2007; Hill et al. 2004; Krabbendam et al. 2005; Schretlen et al. 2007)</span><span>. </span><span>Perhaps one of the clearest examples of such a result was recently provided by Reichenberg and colleagues </span><span>(Reichenberg et al. 2008)</span><span>. These researchers compared individuals with consensus research diagnoses of schizophrenia, schizoaffective disorder, major depressive disorder with affective features and bipolar disorder with psychotic features.<span>  </span>The individuals with schizophrenia and schizoaffective disorder were overall more impaired than the individuals with psychotic mood disorders, and the prevalence of cognitive impairment was higher in schizophrenia and schizoaffective disorder by definitions that they examined.<span>  </span>However, the individuals within all four groups showed the same <i>relative</i> pattern of impairment across cognitive domains, with the greatest impairment in verbal memory, and the least impairment in visual processing general verbal ability. Depp et al provided another compelling example in their studying comparing individuals with schizophrenia, bipolar disorder and healthy controls </span><span>(Depp et al. 2007)</span><span>.<span>  </span>Unlike, Reichenberg et al., Depp found that the bipolar patients were as impaired as the schizophrenia patients on many of the tests.<span>  </span>Further, the profile of impairment was very similar across groups, with the most impairment in information processing speed for both groups, and the least impairment in crystallized IQ.<span>  </span>In addition, there is evidence that the factor structure of cognition is very similar across schizophrenia and bipolar disorder </span><span>(Czobor et al. 2007)</span><span>. There are of course some exceptions to these results, and some studies that have shown differences across psychotic disorders in the pattern or severity of cognitive impairment </span><span>(Heinrichs et al. 2008a)</span><span>. However, the wealth of data suggest that this separation is not sufficient to justify inclusion of cognition as a Criterion A symptom of schizophrenia.</span></font></font></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>Nonetheless, it remains clear that cognitive function is important for understanding functional status in schizophrenia </span><span>(Bowie et al. 2008; Green et al. 2000; Green et al. 2004)</span><span>, as well as other psychotic disorders, including bipolar disorder </span><span>(Gruber et al. 2008; Jaeger et al. 2007; Martinez-Aran et al. 2004; Tabares-Seisdedos et al. 2008)</span><span>, and<span>  </span>that cognitive </span><span>deficits are not well treated by current antipsychotic medications </span><span>(e.g., Keefe et al. 2007)</span><span>.<span>  </span>Thus, we have included a dimensional assessment of cognition because it is important to highlight the potential need for additional treatments specifically targeting cognitive remediation in schizophrenia and other psychotic disorders </span><span>(e.g., Marder 2006; Marder and Fenton 2004)</span><span>.<span>  </span>We will be recommending that it is optimal to obtain a formal neuropsychological assessment in individuals with psychosis to fully understand the nature and severity of their cognitive impairments.<span>  </span>However, should this not be possible, we will be recommending that at minimum, clinicians conduct a brief and easy to validity administer assessment of cognition such as one of the many variations of the Digit Symbol Substitution Test.<span>  </span>These measures are very brief (under 5 minutes), are highly reliable, and are strong predictors of the severity of cognitive impairments shown by individuals with schizophrenia on large batteries of cognitive tests </span><span>(Dickinson 2008; Dickinson et al. 2008; Dickinson et al. 2007)</span><span>. The growing research on other methods for assessing cognitive function (e.g., self-report, clinician interview) suggests that these methods do not provide valid assessments of objective cognition impairment or functional outcome in psychosis</span><span>(Green et al. 2008)</span><span> and thus these are not sufficient as a basis for assessing cognitive impairment in schizophrenia.</span></font></font></p>
<p style="text-align:justify;margin-top:6pt" class="MsoNormal" align="left"><span><font size="2" face="Arial">Depression and Mania</font></span></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>We also propose to include dimensional assessments of depression and mania for all psychotic disorders.<span>  </span>There is growing evidence that schizoaffective disorder does not represent a distinct nosological category separate form schizophrenia </span><span>(e.g., Malhi et al. 2008; Owen et al. 2007; Peralta and Cuesta 2009)</span><span>. However, at the same time there is good evidence that the severity of the mood pathology present in individuals with schizophrenia indicates important information about prognosis and outcome </span><span>(Bowie et al. 2006; Crumlish et al. 2005)</span><span>, and the need for treatments specifically targeting these mood symptoms </span><span>(e.g., Addington et al. 1998; Peralta and Cuesta 2009)</span><span>.<span>  </span>Thus, dimensional assessments of depression and mania for all psychotic disorders will serve to alert clinicians to look for the presence of mood pathology and treat it were appropriate. <span> </span></span></font></font></p>
<p align="left"><span><font size="2" face="Arial"><strong>References</strong></font></span></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Addington, D.; Addington, J.; and Patten, S. Depression in people with first-episode schizophrenia. <i>Br J Psychiatry Suppl</i>, 172(33):90-2, 1998.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Addington, J., and Mancuso, E. Cognitive-behavioral therapy for individuals at high risk of developing psychosis. <i>J Clin Psychol</i>, 65(8):879-90, 2009.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Barch, D.M.; Carter, C.S.; and Cohen, J.D. Context processing deficit in schizophrenia:<span>  </span>Diagnostic specificity, 4-week course, and relationships to clinical symptoms. <i>Journal of Abnormal Psychology</i>, 112(132-143), 2003.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Barch, D.M.; Mitropoulou, V.; Harvey, P.D.; New, A.S.; Silverman, J.M.; and Siever, L.J. Context-processing deficits in schizotypal personality disorder. <i>Journal of Abnormal Psychology</i>, 113(4):556-68, 2004.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Bowie, C.R.; Leung, W.W.; Reichenberg, A.; McClure, M.M.; Patterson, T.L.; Heaton, R.K.; and Harvey, P.D. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. <i>Biol Psychiatry</i>, 63(5):505-11, 2008.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Bowie, C.R.; Reichenberg, A.; Patterson, T.L.; Heaton, R.K.; and Harvey, P.D. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. <i>Am J Psychiatry</i>, 163(3):418-25, 2006.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Cervellione, K.L.; Burdick, K.E.; Cottone, J.G.; Rhinewine, J.P.; and Kumra, S. Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-term functional outcome. <i>Journal of the American Academy of Child and Adolescent Psychiatry</i>, 46(7):867-78, 2007.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Crumlish, N.; Whitty, P.; Kamali, M.; Clarke, M.; Browne, S.; McTigue, O.; Lane, A.; Kinsella, A.; Larkin, C.; and O'Callaghan, E. Early insight predicts depression and attempted suicide after 4 years in first-episode schizophrenia and schizophreniform disorder. <i>Acta Psychiatr Scand</i>, 112(6):449-55, 2005.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Czobor, P.; Jaeger, J.; Berns, S.M.; Gonzalez, C.; and Loftus, S. Neuropsychological symptom dimensions in bipolar disorder and schizophrenia. <i>Bipolar Disord</i>, 9(1-2):71-92, 2007.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Delawalla, Z.; Barch, D.M.; Fisher Eastep, J.L.; Thomason, E.S.; Hanewinkel, M.J.; Thompson, P.A.; and Csernansky, J.G. Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia. <i>Schizophrenia Bulletin</i>, 2006.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Depp, C.A.; Moore, D.J.; Sitzer, D.; Palmer, B.W.; Eyler, L.T.; Roesch, S.; Lebowitz, B.D.; and Jeste, D.V. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects. <i>J Affect Disord</i>, 101(1-3):201-9, 2007.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Dichter, G.S.; Bellion, C.; Casp, M.; and Belger, A. Impaired Modulation of Attention and Emotion in Schizophrenia. <i>Schizophr Bull</i>, 2009.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Dickinson, D. Digit symbol coding and general cognitive ability in schizophrenia: worth another look? <i>Br J Psychiatry</i>, 193(5):354-6, 2008.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Dickinson, D.; Ragland, J.D.; Gold, J.M.; and Gur, R.C. General and specific cognitive deficits in schizophrenia: Goliath defeats David? <i>Biol Psychiatry</i>, 64(9):823-7, 2008.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Dickinson, D.; Ramsey, M.E.; and Gold, J.M. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. <i>Archives<span>  </span>of General Psychiatry</i>, 64(5):532-42, 2007.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Dowd, E., and Barch, D.M. Subjective emotional experience in schizophrenia:<span>  </span>Neural and behavioral markers. <i>Biological Psychiatry</i>, in press.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Fahim, C.; Stip, E.; Mancini-Marie, A.; Mensour, B.; Boulay, L.J.; Leroux, J.M.; Beaudoin, G.; Bourgouin, P.; and Beauregard, M. Brain activity during emotionally negative pictures in schizophrenia with and without flat affect: an fMRI study. <i>Psychiatry Res</i>, 140(1):1-15, 2005.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Gleeson, J.F.; Cotton, S.M.; Alvarez-Jimenez, M.; Wade, D.; Gee, D.; Crisp, K.; Pearce, T.; Newman, B.; Spiliotacopoulos, D.; Castle, D.; and McGorry, P.D. A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. <i>J Clin Psychiatry</i>, 70(4):477-86, 2009.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Green, M.F.; Kern, R.S.; Braff, D.L.; and Mintz, J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the &quot;right stuff&quot;? <i>Schizophrenia Bulletin Special Issue: Psychosocial treatment for schizophrenia</i>, 26(1):119-136, 2000.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Green, M.F.; Kern, R.S.; and Heaton, R.K. Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS. <i>Schizophrenia Research</i>, 72(1):41-51, 2004.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Green, M.F.; Nuechterlein, K.H.; Kern, R.S.; Baade, L.E.; Fenton, W.S.; Gold, J.M.; Keefe, R.S.; Mesholam-Gately, R.; Seidman, L.J.; Stover, E.; and Marder, S.R. Functional Co-Primary Measures for Clinical Trials in Schizophrenia: Results From the MATRICS Psychometric and Standardization Study. <i>Am J Psychiatry</i>, 2008.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Gruber, S.A.; Rosso, I.M.; and Yurgelun-Todd, D. Neuropsychological performance predicts clinical recovery in bipolar patients. <i>J Affect Disord</i>, 105(1-3):253-60, 2008.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Gur, R.E.; Kohler, C.G.; Ragland, J.D.; Siegel, S.J.; Lesko, K.; Bilker, W.B.; and Gur, R.C. Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures. <i>Schizophr Bull</i>, 32(2):279-87, 2006.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Gur, R.E.; Loughead, J.; Kohler, C.G.; Elliott, M.A.; Lesko, K.; Ruparel, K.; Wolf, D.H.; Bilker, W.B.; and Gur, R.C. Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia. <i>Arch Gen Psychiatry</i>, 64(12):1356-66, 2007.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Heinrichs, R.W.; Ammari, N.; McDermid Vaz, S.; and Miles, A.A. Are schizophrenia and schizoaffective disorder neuropsychologically distinguishable? <i>Schizophr Res</i>, 99(1-3):149-54, 2008a.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Heinrichs, R.W.; Goldberg, J.O.; Miles, A.A.; and McDermid Vaz, S. Predictors of medication competence in schizophrenia patients. <i>Psychiatry Research</i>, 157(1-3):47-52, 2008b.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Henry, J.D.; Green, M.J.; de Lucia, A.; Restuccia, C.; McDonald, S.; and O'Donnell, M. Emotion dysregulation in schizophrenia: reduced amplification of emotional expression is associated with emotional blunting. <i>Schizophr Res</i>, 95(1-3):197-204, 2007.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Hill, S.K.; Keshavan, M.S.; Thase, M.E.; and Sweeney, J.A. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. <i>Am J Psychiatry</i>, 161(6):996-1003, 2004.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Jaeger, J.; Berns, S.; Loftus, S.; Gonzalez, C.; and Czobor, P. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. <i>Bipolar Disord</i>, 9(1-2):93-102, 2007.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Keefe, R.S.; Bilder, R.M.; Davis, S.M.; Harvey, P.D.; Palmer, B.W.; Gold, J.M.; Meltzer, H.Y.; Green, M.F.; Capuano, G.; Stroup, T.S.; McEvoy, J.P.; Swartz, M.S.; Rosenheck, R.A.; Perkins, D.O.; Davis, C.E.; Hsiao, J.K.; and Lieberman, J.A. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. <i>Archives of General<span>  </span>Psychiatry</i>, 64(6):633-47, 2007.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Kerns, J.B., and Berenbaum, H. Cognitive impairments associated with formal thought disorder in people with schizophrenia. <i>Journal of Abnormal Psychology</i>, 111(2):211-224, 2002.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Krabbendam, L.; Arts, B.; van Os, J.; and Aleman, A. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. <i>Schizophr Res</i>, 80(2-3):137-49, 2005.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Kraepelin, E. <i>Dementia praecox and paraphrenia</i>. Edinburgh: Livingston (Original work published 1919), 1971.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Malaspina, D., and Coleman, E. Olfaction and social drive in schizophrenia. <i>Arch Gen Psychiatry</i>, 60(6):578-84, 2003.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Malhi, G.S.; Green, M.; Fagiolini, A.; Peselow, E.D.; and Kumari, V. Schizoaffective disorder:<span>  </span>Diagnostic issues and future recommendations. <i>Bipolar DIsorders</i>, 10:215-230, 2008.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Marder, S.R. Drug initiatives to improve cognitive function. <i>Journal of Clinical Neuropsychiatry</i>, 67 Suppl 9:31-5; discussion 36-42, 2006.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Marder, S.R., and Fenton, W. Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. <i>Schizophrenia Research</i>, 72(1):5-9, 2004.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Martinez-Aran, A.; Vieta, E.; Reinares, M.; Colom, F.; Torrent, C.; Sanchez-Moreno, J.; Benabarre, A.; Goikolea, J.M.; Comes, M.; and Salamero, M. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. <i>Am J Psychiatry</i>, 161(2):262-70, 2004.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">McClure, M.M.; Bowie, C.R.; Patterson, T.L.; Heaton, R.K.; Weaver, C.; Anderson, H.; and Harvey, P.D. Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships? <i>Schizophr Res</i>, 89(1-3):330-8, 2007.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Owen, M.J.; Craddock, N.; and Jablensky, A. The genetic deconstruction of psychosis. <i>Schizophrenia Bulletin</i>, 33(4):905-911, 2007.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Peralta, V., and Cuesta, M.J. Exploring the borders of the schizoaffective spectrum:<span>  </span>A categorial and dimensional approach. <i>Journal of Affective Disorders</i>, 108:71-86, 2009.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Perlstein, W.M.; Dixit, N.K.; Carter, C.S.; Noll, D.C.; and Cohen, J.D. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. <i>Biological Psychiatry</i>, 53:25-38, 2003.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Reichenberg, A.; Harvey, P.D.; Bowie, C.R.; Mojtabai, R.; Rabinowitz, J.; Heaton, R.K.; and Bromet, E. Neuropsychological Function and Dysfunction in Schizophrenia and Psychotic Affective Disorders. <i>Schizophr Bull</i>, 2008.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Schretlen, D.J.; Cascella, N.G.; Meyer, S.M.; Kingery, L.R.; Testa, S.M.; Munro, C.A.; Pulver, A.E.; Rivkin, P.; Rao, V.A.; Diaz-Asper, C.M.; Dickerson, F.B.; Yolken, R.H.; and Pearlson, G.D. Neuropsychological functioning in bipolar disorder and schizophrenia. <i>Biol Psychiatry</i>, 62(2):179-86, 2007.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Smith, M.J.; Barch, D.M.; and Csernansky, J.G. Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology. <i>Schizophr Res</i>, 107(1):69-75, 2009.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Strauss, G.P.; Miski, P.; Fisher, B.A.; Kirkpatrick, B.; Buchanan, R.W.; and Carpenter, W.T. Deconstructing negative symptoms of schizophrenia: Avolition-apathy and emotional expression clusters predict clinical presentation and functional outcome. in submission.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Strauss, M.E.; Buchanan, R.W.; and Hale, J. Relations between attentional deficits and clinical symptoms in schizophrenic outpatients. <i>Psychiatry Research</i>, 47:205-213, 1993.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Suslow, T.; Junghanns, K.; Weitzsch, C.; and Arolt, V. Relations between neuropsychological vulnerability markers and negative symptoms in schizophrenia. <i>Psychopathology</i>, 31(4):178-87, 1998.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Tabares-Seisdedos, R.; Balanza-Martinez, V.; Sanchez-Moreno, J.; Martinez-Aran, A.; Salazar-Fraile, J.; Selva-Vera, G.; Rubio, C.; Mata, I.; Gomez-Beneyto, M.; and Vieta, E. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. <i>J Affect Disord</i>, 109(3):286-99, 2008.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Tattan, T.M., and Creed, F.H. Negative symptoms of schizophrenia and compliance with medication. <i>Schizophr Bull</i>, 27(1):149-55, 2001.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Velligan, D.I. Cognitive behavior therapy for psychosis: where have we been and where are we going? <i>Schizophr Bull</i>, 35(5):857-8, 2009.</font><font size="2" face="Arial"> </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font face="Arial"><font size="2">Waltz, J.A.; Schweitzer, J.B.; Gold, J.M.; Kurup, P.K.; Ross, T.J.; Salmeron, B.J.; Rose, E.J.; McClure, S.M.; and Stein, E.A. Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. <i>Neuropsychopharmacology</i>, 34(6):1567-77, 2009.</font><font size="2"> </font></font></p></span></span></div></div></div><div id="DSM_TabContent_DSM-IV"><p class="MsoNormal"><span style="font-family:'arial', 'sans-serif';font-size:10pt"><span>Among the work group’s proposals is the recommendation for an <a title="" href="../../proposedrevision/Pages/proposedrevision_rid_412.html" target="_blank">Attenuated Psychosis Syndrome</a> to be part of Section III of the DSM-5. This proposal is under examination as part of the DSM-5 Field Trials, and the work group hopes to gather significant feedback from the public about this recommendation.</span></p>
<p class="MsoNormal"></span> </p></div></td></tr></table></td></tr></table><table cellspacing="0" cellpadding="4" border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr></tr></table></div></td>
			</tr>
		</table><div class="ms-PartSpacingVertical"></div></td>
	</tr><tr>
		<td id="MSOZoneCell_WebPartWPQ4" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="f02ada8a-2400-4fe7-8d10-03411362e842" haspers="false" id="WebPartWPQ4" width="100%" class="ms-WPBody" allowdelete="false" style=""><script type="text/javascript">
$(document).ready(function() {
  TabClick('Proposed','Rationale','Severity','DSM-IV');
});
</script></div></td>
			</tr>
		</table></td>
	</tr>
</table>								
	</div>
	<div id="DSM_RightCol">
		<div id="DSM_int_topRight">	
		</div>
		<div id="DSM_int_btmRight">
			<div id="ctl00_PlaceHolderMain_ctl00__ControlWrapper_RichHtmlField" style="display:inline"></div>						
			<table width="100%" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td id="MSOZoneCell_WebPartWPQ3" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="3cf5e074-39b0-425f-92e8-f3c760a6ce71" haspers="false" id="WebPartWPQ3" width="100%" allowdelete="false" allowexport="false" style=""><table width="100%" cellspacing="0" cellpadding="0" border="0"><script>
ctx = new ContextInfo();
ctx.listBaseType = 0;
ctx.listTemplate = 103;
ctx.listName = "{59E5C57E-4B33-4F74-B28B-5BDB9754C4FB}";
ctx.view = "{3CF5E074-39B0-425F-92E8-F3C760A6CE71}";
ctx.listUrlDir = "\u002fproposedrevision\u002fLists\u002fRelated\u002520Links";
ctx.HttpPath = "\u002fproposedrevision\u002f_vti_bin\u002fowssvr.dll?CS=65001";
ctx.HttpRoot = "https:\u002f\u002f\u002fweb\u002f20121020115104\u002fhttp:\u002f\u002fwww.dsm5.org\u002fproposedrevision";
ctx.imagesPath = "\u002f_layouts\u002fimages\u002f";
ctx.PortalUrl = "";
ctx.SendToLocationName = "";
ctx.SendToLocationUrl = "";
ctx.RecycleBinEnabled = -1;
ctx.OfficialFileName = "";
ctx.WriteSecurity = "1";
ctx.SiteTitle = "Proposed Revisions";
ctx.ListTitle = "Related Links";
if (ctx.PortalUrl == "") ctx.PortalUrl = null;
ctx.displayFormUrl = "\u002fproposedrevision\u002fLists\u002fRelated\u002520Links\u002fDispForm.aspx";
ctx.editFormUrl = "\u002fproposedrevision\u002fLists\u002fRelated\u002520Links\u002fEditForm.aspx";
ctx.isWebEditorPreview = 0;
ctx.ctxId = 1;
g_ViewIdToViewCounterMap[ "{3CF5E074-39B0-425F-92E8-F3C760A6CE71}" ]= 1;
ctx.CurrentUserId = -1;
ctx1 = ctx;
</script><tr><td><table id="{59E5C57E-4B33-4F74-B28B-5BDB9754C4FB}-{3CF5E074-39B0-425F-92E8-F3C760A6CE71}" summary="Related Links" o:webquerysourcehref="http://www.dsm5.org/proposedrevision/_vti_bin/owssvr.dll?CS=65001&amp;XMLDATA=1&amp;RowLimit=0&amp;List={59E5C57E-4B33-4F74-B28B-5BDB9754C4FB}&amp;View={3CF5E074-39B0-425F-92E8-F3C760A6CE71}" class="ms-summarycustombody" style="margin-bottom: 5px;" cellpadding="0" cellspacing="0" border="0">
                        <tr>
                            <td style="padding-bottom: 5px" class="ms-vb"><img src="../../_layouts/images/square.gif" alt="">&nbsp;</td>
                            <td style="padding-bottom: 5px;padding-left: 5px;" class="ms-vb">
                        <a onfocus="OnLink(this)" href="http://www.psych.org/">American Psychiatric Association</a>
                            </td>
                        </tr>
                        <tr>
                            <td style="padding-bottom: 5px" class="ms-vb"><img src="../../_layouts/images/square.gif" alt="">&nbsp;</td>
                            <td style="padding-bottom: 5px;padding-left: 5px;" class="ms-vb">
                        <a onfocus="OnLink(this)" href="../../proposedrevision/Pages/proposed-dsm5-organizational-structure-and-disorder-names.html">Proposed DSM-5 Organizational Structure</a>
                            </td>
                        </tr>
                        <tr>
                            <td style="padding-bottom: 5px" class="ms-vb"><img src="../../_layouts/images/square.gif" alt="">&nbsp;</td>
                            <td style="padding-bottom: 5px;padding-left: 5px;" class="ms-vb">
                        <a onfocus="OnLink(this)" href="../../Pages/RecentUpdates.html">Recent Updates to Proposed Revisions for DSM-5</a>
                            </td>
                        </tr>
                    </table></td></tr></table><table id="ECBItems" style="display:none" height="0" width="0"><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XsnLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xsn</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.2</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.3</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.4</td><td>255</td></tr><tr><td>View in Web Browser</td><td>/_layouts/images/ichtmxls.gif</td><td>/proposedrevision/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&DefaultItemOpen;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsx</td><td>255</td></tr><tr><td>View in Web Browser</td><td>/_layouts/images/ichtmxls.gif</td><td>/proposedrevision/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&DefaultItemOpen;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsb</td><td>255</td></tr><tr><td>Snapshot in Excel</td><td>/_layouts/images/ewr134.gif</td><td>/proposedrevision/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&Snapshot;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsx</td><td>256</td></tr><tr><td>Snapshot in Excel</td><td>/_layouts/images/ewr134.gif</td><td>/proposedrevision/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&Snapshot;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsb</td><td>256</td></tr></table></div></td>
			</tr>
		</table></td>
	</tr>
</table>						
		</div>						
	</div>	
	<div class="DSM_clear"><img src="../../Style Library/DSM_Images/clear.gif" width="1" height="1" alt=""/></div>	
<!---- end MAIN CONTENT AREA ---->
			</div>
			<div id="DSM_Footer">
				<p class="DSM_Tagline">Representing 36,000 physician leaders in mental health.</p>
				<p>© <strong>2012 American Psychiatric Association.</strong> All Rights Reserved.<br/>
				Use of all Materials on this Website is subject to the <a href="../../Pages/PermissionsPolicy.html">APA Permissions Policy</a> and <a href="../../Pages/TermsandConditionsofUse.html">Terms and Conditions of Use.</a><br/>
				<br/>  
				1000 Wilson Boulevard, Suite 1825, Arlington, Va. 22209-3901<br/>
				phone: 703-907-7300 <a href="mailto:apa@psych.org?subject=DSM5:">email: apa@psych.org</a></p>
				<div class="DSM_SocialLinks">
	 				<table>
	 					<tr>
	 						<td>Find us on:</td>
							<td><a href="http://www.facebook.com/pages/DSM-5-Diagnostic-and-Statistical-Manual-of-Mental-Disorders/260197062886" target="_blank"><img src="../../Style Library/DSM_Images/facebook.gif" width="58" height="15" alt="Find us on Facebook"/></a></td>
							<td><a href="http://twitter.com/dsm5" target="_blank"><img src="../../Style Library/DSM_Images/twitter.jpg" width="60" height="20" alt="Find us on Twitter"/></a></td>
						</tr>
	 				</table>
				</div>
				<p><a href="../../pages/Contactus.html">Contact Us For Help</a></p>
			</div>		
		</div>
<!-- end MAIN LAYOUT -->
<!-- begin EDITOR POSITIONING DIV -->
	<div id="ctl00_MSO_ContentDiv" class="SP_editorPosition">&nbsp;</div>
<!-- end EDITOR POSITIONING DIV -->
<!-- begin HIDDEN MASTER PAGE ELEMENTS -->
	<div style="display:none">
			<div class="breadcrumb">
				<span id="ctl00_PlaceHolderTitleBreadcrumb_siteMapPath"><a href="#ctl00_PlaceHolderTitleBreadcrumb_siteMapPath_SkipLink"><img alt="Skip Navigation Links" height="0" width="0" src="../../WebResource.axd_d_nmHMzpcb8opA4_TBGiLLxg2_t_633965588901821931.jpg" border="0"/></a><span><a class="ms-sitemapdirectional" href="/">Home</a></span><span> &gt; </span><span><a title="DSM-5 Proposed Revisions" class="ms-sitemapdirectional" href="../../proposedrevision/Pages/Default.html">Proposed Revisions</a></span><span> &gt; </span><span class="breadcrumbCurrent">Proposed Revision</span><a id="ctl00_PlaceHolderTitleBreadcrumb_siteMapPath_SkipLink"></a></span>
			</div>
	</div>
<!-- end HIDDEN MASTER PAGE ELEMENTS -->
<script type="text/javascript">
//<![CDATA[
var __wpmExportWarning='This Web Part Page has been personalized. As a result, one or more Web Part properties may contain confidential information. Make sure the properties contain information that is safe for others to read. After exporting this Web Part, view properties in the Web Part description file (.WebPart) by using a text editor such as Microsoft Notepad.';var __wpmCloseProviderWarning='You are about to close this Web Part.  It is currently providing data to other Web Parts, and these connections will be deleted if this Web Part is closed.  To close this Web Part, click OK.  To keep this Web Part, click Cancel.';var __wpmDeleteWarning='You are about to permanently delete this Web Part.  Are you sure you want to do this?  To delete this Web Part, click OK.  To keep this Web Part, click Cancel.';var zz1_TopNavigationMenu_Data = new Object();
zz1_TopNavigationMenu_Data.disappearAfter = 500;
zz1_TopNavigationMenu_Data.horizontalOffset = 0;
zz1_TopNavigationMenu_Data.verticalOffset = 0;
zz1_TopNavigationMenu_Data.hoverClass = 'DSM_dynamicNavHover';
if (typeof(overrideMenu_HoverStatic) == 'function' && typeof(Menu_HoverStatic) == 'function')
{
_spBodyOnLoadFunctionNames.push('enableFlyoutsAfterDelay');
Menu_HoverStatic = overrideMenu_HoverStatic;
}
var flyoutsAllowed = false;
function enableFlyoutsAfterDelay()
{
setTimeout('flyoutsAllowed = true;', 50);
}
function overrideMenu_HoverStatic(item)
{
if (!flyoutsAllowed || (document.readyState != null && document.readyState != 'complete'))
{
setTimeout(delayMenu_HoverStatic(item), 50);
}
else
{
// this code is the default ASP.NET implementation of Menu_HoverStatic
var node = Menu_HoverRoot(item);
var data = Menu_GetData(item);
if (!data) return;
__disappearAfter = data.disappearAfter;
Menu_Expand(node, data.horizontalOffset, data.verticalOffset);
}
}
function delayMenu_HoverStatic(item)
{
return (function()
{
overrideMenu_HoverStatic(item);
});
}
//]]>
</script>
</form>
  <!-- Google Code -->
  <script type="text/javascript">
  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-16139255-17']);
  _gaq.push(['_setDomainName', '.dsm5.org']);
  _gaq.push(['_trackPageview']);
  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + 
'.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();
</script>
</body>
</html>